Silexion Therapeutics (SLXN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

SLXN Silexion Therapeutics

Watchlist

2.140
-0.760-26.21%

Close Dec 18 16:00 ET

2.480
+0.340+15.87%

Post 20:01 ET

3.43MMarket Cap-0.12P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

PESG Releases Market Update: Silexion Therapeutics Advances KRAS-Targeting Therapies With New Collaboration As Industry Demand for Precision Oncology Solutions Rises
BusinesswireDec 17 09:36 ET
Silexion Therapeutics Collaborates With Evonik on Advanced SiRNA Formulation Development
GlobeNewswireDec 17 06:30 ET
Express News | Silexion Therapeutics Collaborates With Evonik on Advanced Sirna Formulation Development
ReutersDec 17 06:30 ET
Top Premarket Gainers
MT NewswiresDec 11 07:40 ET
Trending Stocks Today | SEALSQ Corp Shoots up 118.91% Pre-Market
Moomoo NewsDec 11 05:35 ET
Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
BenzingaDec 11 05:27 ET

Comments

Jaguar8

7 hours ago

🟢 Watchlist THURSDAY December 19,2024. NFA!

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Currenc Group (CURR.US)$ Despac Sk...

The GAME

Dec 17 08:45

$Silexion Therapeutics (SLXN.US)$ Drop until no people want to buy. no volume at all

Jaguar8

Dec 13 18:10

🕛Watchlist MONDAY December 16. NFA. Trade the chart. Be kind… in progress

$Gorilla Technology (GRRR.US)$ PR: CEO will have interview with Red Chip Small Stock, Big Money show on Sat Dec 14. Reports on CEO on X that they have been selected from the shortlist for the $438M deal in SE Asia. Low float. $23.2M cash good for 12 months
$Checkpoint Therapeutics (CKPT.US)$ $Fortress Biotech (FBIO.US)$ FDA approval of drug for metastatic cutaneous squamous cell carcinoma. This drug is the first and only progr...